Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001601830-25-000078
Filing Date
2025-05-05
Accepted
2025-05-05 06:07:27
Documents
16
Effectiveness Date
2025-05-05

Document Format Files

Seq Description Document Type Size
1 S-8 a2025s-8xeipespp.htm S-8 80614
2 EX-107 exfilingfees.htm   iXBRL EX-FILING FEES 31568
3 EX-5.1 ex51-wsgropinion2025.htm EX-5.1 7660
4 EX-23.1 exhibit231pwcconsentletter.htm EX-23.1 2222
5 image_1.jpg GRAPHIC 68421
  Complete submission text file 0001601830-25-000078.txt   357878

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 9275
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286963 | Film No.: 25910779
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)